SAAD, Fred et al. Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. Canadian Urological Association Journal, [S. l.], v. 10, n. 3-4, p. 102–9, 2016. DOI: 10.5489/cuaj.3470. Disponível em: https://cuaj.ca/index.php/journal/article/view/3470. Acesso em: 26 may. 2026.